当前位置:Public Access >页面
Chinese/English
safety and efficacy study of T cells modified with human Chimeric antigen receptor gene targeting CD19 in the treatment of CD19 positive malignant b-cell leukemia or lymphoma
Filter Options
Patient No. Patient Name Patient Gender
Sitting Education Date of enrollment FromTo
       More Options
Patient No Gender Date of enrollment Sitting Creater Operate
NO participants recorded。